Article Details

Durability of mRNA-1273 Protection Against Symptomatic COVID-19 Examined

Retrieved on: 2022-06-13 18:26:39

Tags for this article:

Click the tags to see associated articles and topics

Durability of mRNA-1273 Protection Against Symptomatic COVID-19 Examined. View article details on hiswai:

Excerpt

MONDAY, June 13, 2022 (HealthDay News) -- For individuals who receive two doses of mRNA-1273 severe acute respiratory syndrome coronavirus 2 ...

Article found on: journalstar.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up